Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T10486 |
BCI
(E)-BCI |
Phosphatase | Metabolism |
BCI ((E)-BCI) 是双重特异性磷酸酶的变构抑制剂。它特异性抑制 DUSP6和 DUSP1的 EC50分别为 13.3 和 8.0 μM,但不能够抑制 DUSP5。 | |||
T23777 |
BCI-137
BCI137 |
Others | Others |
BCI-137 是 Argonaute 2 配体。它通过靶向 MicroRNA 结合域来发挥作用。 | |||
T5322 |
BCI-121
|
Histone Methyltransferase | Chromatin/Epigenetic |
BCI-121是一种底物竞争性 SMYD3 抑制剂,可抑制癌细胞的增殖。 | |||
T7323 |
BCI-215
|
Phosphatase | Metabolism |
BCI-215 是高效肿瘤细胞选择性的双重特异性磷酸酶DUSP-MKP 抑制剂。它对肿瘤细胞有细胞毒性,但对正常细胞无毒性。 | |||
T11139 |
(E/Z)-BCI
NSC 150117 |
Apoptosis; Phosphatase | Apoptosis; Metabolism |
(E/Z)-BCI (NSC-150117) 是一种DUSP6抑制剂,可通过激活 Nrf2 信号和抑制 NF-κB 通路,减弱 LPS 诱导的巨噬细胞炎症和 ROS 生成,具有抗炎活性。 | |||
T10486L |
BCI hydrochloride
(E)-BCI hydrochloride |
Others | Others |
BCI hydrochloride specifically inhibits DUSP6 and DUSP1 with EC50s of 13.3 and 8.0 μM in cells, respectively. BCI hydrochloride does not inhibit DUSP5. BCI hydrochloride is an allosteric inhibitor of dual specificity phosphatase (DUSP). | |||
T28034 |
MGS-0039
BCI 632,BCI-632,MGS0039,BCI632 |
||
MGS-0039 is a group II metabotropic glutamate receptor (mgluR2/3) antagonist. Antidepressant-like action of group II mGlu receptor antagonists does not depend on serotonergic system activation. However, the AMPA receptor seems to play a key role in the an | |||
T28654 |
Sabcomeline hydrochloride
BCI224,BRL-55473,BCI-224,CEB-2424,SB-202026A,Sabcomeline HCl |
||
Sabcomeline is a selective M1 receptor partial agonist. | |||
T76844 |
Abciximab
C7E3 |
Integrin | Cytoskeletal Signaling |
Abciximab (C7E3) 是一种小鼠/人嵌合单克隆抗体,是一种有效的糖蛋白 IIb/IIIa (glycoprotein IIb/IIIa) 抑制剂。 Abciximab 具有抗血小板聚集和白细胞粘附的作用,通过与糖蛋白 IIb/IIIa、vitronectin 和 Mac-1 受体结合发挥作用。 | |||
T18923 |
BCIP
5-溴-4-氯-3-吲哚基磷酸酯对甲苯胺盐,BCIP p-toluidine salt,X-phosphate p-toluidine salt |
Others | Others |
BCIP (BCIP p-toluidine salt) 是一种显色底物,可用于碱性磷酸酶活性的比色法检测。 | |||
T6415 |
Bismuth Subcitrate Potassium
|
Others; Antibacterial; Antibiotic | Microbiology/Virology; Others |
Bismuth subcitrate potassium 是针对 12 种幽门螺杆菌菌株的抗生素,MIC50为 8 μg/ml。它用于幽门螺杆菌感染的上胃肠道疾病的研究。 | |||
T31223 |
DCBCI0901
DCBCI-0901,DCBCI 0901 |
||
DCBCI0901 is an inhibitor of phosphatidylinositide 3-kinase (PI3K), raptor-mTOR (mTOR complex 1 or mTORC1) and rictor-mTOR (mTOR complex 2 or mTORC2) with potential antineoplastic activity. |